<DOC>
	<DOCNO>NCT02556411</DOCNO>
	<brief_summary>Adenomyosis characterize appearance endometrial cell muscular layer uterus . It affect 15-20 % female population . The symptoms adenomyosis heavy menstrual bleeding painful menstruation ( dysmenorrhea ) addition chronic pelvic pain . Regarding treatment levonogestrel-releasing intrauterine system , Gonadotropin release hormone ( GnRH ) -analogues , Danazol , uterine embolization endometrial ablation try . The aim study compare efficacy usefulness association oral contraceptive pill LNG-IUS LNG-IUS alone</brief_summary>
	<brief_title>Comparison Estrogen-progestin Therapy Continuous Regimen Versus Combination Estrogen-progestin Therapy Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System ( LNG-IUS )</brief_title>
	<detailed_description />
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Women affect adenomyosis pelvic pain &gt; 4 ; Negative Pap Smear test Pregnancy research pregnancy Refusal inability sign inform consent Severe underlie comorbidities ( hepatic , oncological ) Pelvic inflammatory disease Other cervical uterine pathology Deep venous thromboembolism Hormonal therapy contraindication Smoke</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>